Ulta Beauty, Inc.
Ulta Beauty, Inc. (ULTA) Financial Performance & Income Statement Overview
Review Ulta Beauty, Inc. (ULTA) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Ulta Beauty, Inc. (ULTA) Income Statement & Financial Overview
View the income breakdown for Ulta Beauty, Inc. ULTA across both annual and quarterly reports.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $3.49B | $2.53B | $2.55B | $2.73B |
Cost of Revenue | $2.15B | $1.52B | $1.57B | $1.66B |
Gross Profit | $1.33B | $1.006B | $978.18M | $1.07B |
Gross Profit Ratio | $0.38 | $0.40 | $0.38 | $0.39 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $815.60M | $682.26M | $644.82M | $665.91M |
Operating Expenses | $817.33M | $687.14M | $644.82M | $665.91M |
Total Costs & Expenses | $2.97B | $2.21B | $2.22B | $2.32B |
Interest Income | $1.99M | $1.67M | $4.53M | $6.90M |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | -$1.73M | $67.02M | $65.31M | $64.74M |
EBITDA | $516.32M | $390.41M | $399.04M | $465.69M |
EBITDA Ratio | $0.15 | $0.15 | $0.16 | $0.17 |
Operating Income | $516.32M | $318.50M | $329.20M | $403.87M |
Operating Income Ratio | $0.15 | $0.13 | $0.13 | $0.15 |
Other Income/Expenses (Net) | $1.99M | $1.67M | $4.53M | $6.90M |
Income Before Tax | $518.32M | $320.18M | $333.73M | $407.85M |
Income Before Tax Ratio | $0.15 | $0.13 | $0.13 | $0.15 |
Income Tax Expense | $125.05M | $78.00M | $81.17M | $94.73M |
Net Income | $393.27M | $242.18M | $252.56M | $313.11M |
Net Income Ratio | $0.11 | $0.10 | $0.10 | $0.11 |
EPS | $8.50 | $5.16 | $5.32 | $6.51 |
Diluted EPS | $8.46 | $5.14 | $5.30 | $6.47 |
Weighted Avg Shares Outstanding | $46.27M | $46.93M | $47.51M | $48.13M |
Weighted Avg Shares Outstanding (Diluted) | $46.48M | $47.09M | $47.67M | $48.38M |
Over the last four quarters, Ulta Beauty, Inc. achieved steady financial progress, growing revenue from $2.73B in Q1 2024 to $3.49B in Q4 2024. Gross profit stayed firm with margins at 38% in Q4 2024 versus 39% in Q1 2024. Operating income totaled $516.32M in Q4 2024, maintaining a 15% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $516.32M. Net income rose to $393.27M, with EPS at $8.50. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan